secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001104659-25-004884
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences amends convertible note, extends maturity to April 2025
----------------------------------------------------------------------------

- Maturity extended to earlier of Vyome Therapeutics merger close or 90 days after Jan 14, 2025 (April 16, 2025).
- Mandatory prepayment of subsequent financing proceeds reduced from 66% to 50%.
- Investor not required to convert the note at merger closing; $45,000 cash extension fee payable at maturity.
- Amendment executed with Ascent Partners Fund LLC on $833,333.34 senior secured convertible note.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925004884/0001104659-25-004884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925004884/tm253570d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-004884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer